CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
10 nov. 2017 16h15 HE
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...
CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results
06 nov. 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation
02 nov. 2017 16h55 HE
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation
01 nov. 2017 16h05 HE
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...
CombiMatrix to Present New Data from a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting
20 oct. 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 20, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae
25 sept. 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) (“CombiMatrix” or the “Company”), a family health molecular diagnostics company specializing in DNA-based...
CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results
03 août 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock
31 juil. 2017 16h58 HE
|
CombiMatrix Corporation
$27 million offered to holders of CombiMatrix Common Stock (Nasdaq: CBMX) subject to certain adjustments $6 million offered to holders of CombiMatrix Series F Warrants (Nasdaq: CBMXW) IRVINE,...
CombiMatrix to Present at Upcoming Investor Conferences
22 mai 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., May 22, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results
04 mai 2017 16h05 HE
|
CombiMatrix Corporation
Achieves record reproductive health revenues on higher test volumes and average revenue per test, expands gross margin, significantly narrows operating loss and reports record cash collections ...